Richmond, CA, United States of America

Marshall W Huston

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Sangamo Therapeutics, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marshall W Huston. Retrieved from https://idiyas.com/inventor/marshall-w-huston

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Marshall W Huston: Innovator in Fabry Disease Treatment

Introduction

Marshall W Huston is a notable inventor based in Richmond, CA (US). He has made significant contributions to the field of biotechnology, particularly in the treatment of rare diseases. His work focuses on innovative methods that aim to improve patient outcomes.

Latest Patents

Huston's most recent patent is titled "Methods and compositions for the treatment of Fabry disease." This patent involves nucleases and methods for inserting a sequence encoding a therapeutic α-Gal A protein into a cell. This innovative approach provides proteins or cell therapeutics for the treatment and prevention of Fabry disease. Huston holds 1 patent in this area.

Career Highlights

Marshall W Huston is currently associated with Sangamo Therapeutics, Inc. His role at the company allows him to work on cutting-edge research and development projects aimed at addressing genetic disorders. His expertise in biotechnology has positioned him as a key player in the industry.

Conclusion

Marshall W Huston's contributions to the treatment of Fabry disease through innovative methods and compositions highlight his dedication to advancing medical science. His work continues to inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…